Healthcare Services

Solid Tumor Testing Market Outlook Through 2030 With Analysis Of Industry Trends And Developments

June 3, 2026June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Size Of The Solid Tumor Testing Market In 2026 And How Much Will It Reach By 2030?

The solid tumor testing market has experienced robust expansion in recent years. Projections indicate its value will increase from $29.94 billion in 2025 to $32.11 billion in 2026, driven by a compound annual growth rate (CAGR) of 7.3%. Historically, this growth has been fueled by advances in cancer diagnostics, biomarker discovery, pathology automation, increased oncology awareness, and various screening initiatives.

The solid tumor testing market is anticipated to experience significant expansion over the coming years. Projections indicate it will reach a valuation of $43.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth during the projected timeframe include the rising demand for personalized treatments, an increased emphasis on early detection, the expansion of genomic testing, the integration of AI-driven diagnostics, and the ongoing advancements in oncology research. Key trends expected during this period encompass the rise of liquid biopsy testing, the wider adoption of next-generation sequencing, the broadening scope of companion diagnostics, the incorporation of AI-based pathology, and an increase in screening initiatives.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12658&type=smp

What Major Growth Factors Are Impacting The Solid Tumor Testing Market?

The rising incidence of cancer is projected to propel the expansion of the solid tumor testing market in the coming years. Cancer is a medical condition defined by the unrestrained growth and spread of abnormal cells within the body. These anomalous cells, known as cancer cells, can invade neighboring tissues and organs and, in certain cases, travel to other body areas via the bloodstream or lymphatic system. A significant majority, approximately 90%, of adult cancers are solid tumors. Solid tumor testing is employed to detect cancer cells in the blood of patients with solid tumors, even when the cancer is not yet visible on imaging examinations. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 165,000 Australians were newly diagnosed with cancer in 2023, which corresponds to over 450 cases each day, and males constituted about 55% of these diagnoses. Thus, the increasing prevalence of cancer is a primary driver for the growth of the solid tumor testing market.

What Segment Types Are Included In The Solid Tumor Testing Market Analysis?

The solid tumor testing market covered in this report is segmented –

1) By Type: Genetic Testing, Conventional Testing

2) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer

3) By Application: Clinical, Research

4) By End-Users: Hospitals, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutions

Subsegments:

1) By Genetic Testing: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH)

2) By Conventional Testing: Histopathology, Cytology, Imaging Techniques

What Trends Are Affecting The Growth Of The Solid Tumor Testing Market?

Companies operating within the solid tumor cancer treatment market are focusing on advancing immunotherapies, targeted therapies, and cell-based treatments to enhance patient outcomes and broaden therapeutic options. For instance, in July 2025, Dispatch Bio, a US-based biotechnology company, initiated operations to develop universal treatments for solid tumors. The firm intends to advance new therapeutic approaches designed to target a wide variety of solid tumor types, improve efficacy across different patient populations, and accelerate the development of scalable cancer immunotherapies, with the potential to transform standard-of-care treatment and improve long-term survival rates.

Who Are The Prominent Players Across The Solid Tumor Testing Market?

Major companies operating in the solid tumor testing market are Johnson & Johnson Ltd, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Molecular Inc., Becton Dickinson And Company BD, Quest Diagnostics Incorporated, Tosoh Corporation, Agilent Technologies Inc., bioMerieux Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Miltenyi Biotec GmbH, Natera Inc., Myriad Genetics Inc., Invitae Corporation, Guardant Health Inc., Foundation Medicine Inc., Epic Sciences Inc., Biocare Medical LLC, Agena Bioscience Inc., Caris Life Sciences Inc., 20/20 Gene Systems Inc., Grail Inc., Avant Diagnostics Inc., Genomic Testing Cooperative, Anixa Biosciences Inc., Cellular Biomedicine Group

Access The Complete Solid Tumor Testing Market Report:

https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

Which Region Is The Primary Market For The Solid Tumor Testing Market?

North America was the largest region in the solid tumor testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the solid tumor testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Solid Tumor Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12658&type=smp

Browse Through More Reports Similar to the Global Solid Tumor Testing Market 2026, By The Business Research Company

Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Solid Tumor Cancer Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

Hemato Oncology Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795